Clinical review report Emtricitabine/tenofovir alafenamide fumarate (Descovy)
The objective of this systematic review was to evaluate of the beneficial and harmful effects of the fixed-dose combination of emtricitabine/tenofovir alafenamide fumarate in combination with other antiretrovirals for the treatment of human immunodeficiency virus(HIV)-1 infection in adult and pediat...
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Ottawa, Ontario :
Canadian Agency for Drugs and Technologies in Health
2016.
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820283006719 |
| Sumario: | The objective of this systematic review was to evaluate of the beneficial and harmful effects of the fixed-dose combination of emtricitabine/tenofovir alafenamide fumarate in combination with other antiretrovirals for the treatment of human immunodeficiency virus(HIV)-1 infection in adult and pediatric patients 12 years of age and older (and weighing ≥ 35 kg). |
|---|---|
| Descripción Física: | 1 online resource (1 PDF file (xiii, 69 pages)) : illustrations |
